Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion type Assertion NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_head.
- NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion description "[TRK oncogenes are observed in a consistent fraction of papillary thyroid carcinoma (PTC); they arise from the fusion of the 3' terminal sequences of the NTRK1/NGF receptor gene with 5' terminal sequences of various activating genes, such as TPM3, TPR and TFG.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_provenance.
- NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion evidence source_evidence_literature NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_provenance.
- NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion SIO_000772 19883730 NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_provenance.
- NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion wasDerivedFrom befree-2016 NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_provenance.
- NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_assertion wasGeneratedBy ECO_0000203 NP773267.RA_wHEkWRc93lB9-Fz2F2mh08o_IzO4bm-TlybFCW-MK0130_provenance.